Literature DB >> 11124665

Scar remodeling after strabismus surgery.

I H Ludwig1, A Y Chow.   

Abstract

PURPOSE: We sought to investigate abnormal scar lengthening after strabismus surgery.
METHODS: Patients with overcorrection after strabismus surgery or undercorrection after extraocular muscle resection underwent exploration of previously operated muscles. Abnormal findings were documented by inspection and photography, and repair was undertaken at first with absorbable sutures and later with nonabsorbable sutures.
RESULTS: Lengthened scars, consisting of amorphous connective tissue, were repaired on 198 muscles in 134 procedures by excision of the scar and reattachment of the muscle to sclera; absorbable sutures were used in 64 procedures, and nonabsorbable sutures were used in 70 procedures. Thirty-one procedures were followed by partial recurrence of the original overcorrection; 7 of these had documented restretching. The use of nonabsorbable sutures decreased the recurrence of strabismus from 42% to 6%. Factors that distinguished patients with stretched scars from patients with classic slipped muscles included minimal or no limitation of versions, less separation of the tendons from sclera, and thicker appearance of the scar segments.
CONCLUSIONS: A lengthened or stretched remodeled scar between an operated muscle tendon and sclera may contribute to variability of outcome after strabismus repair, even years later. Definitive repair requires firm reattachment of tendon to sclera with nonabsorbable suture support.

Entities:  

Mesh:

Year:  2000        PMID: 11124665     DOI: 10.1067/mpa.2000.107899

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  16 in total

1.  Three horizontal muscle surgery for large-angle infantile esotropia: validation of a table of amounts of surgery.

Authors:  J E Camuglia; M J Walsh; G A Gole
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

2.  Classifying medial rectus muscle attachment in consecutive exotropia.

Authors:  Jae Ho Jung; David A Leske; Jonathan M Holmes
Journal:  J AAPOS       Date:  2016-05-06       Impact factor: 1.220

3.  Magnetic Resonance Imaging of the Globe-Tendon Interface for Extraocular Muscles: Is There an "Arc of Contact"?

Authors:  Robert A Clark; Joseph L Demer
Journal:  Am J Ophthalmol       Date:  2018-07-19       Impact factor: 5.258

4.  Risk factors for consecutive exotropia after esotropia surgery.

Authors:  So Young Han; Jinu Han; Soolienah Rhiu; Jong Bok Lee; Sueng-Han Han
Journal:  Jpn J Ophthalmol       Date:  2016-05-27       Impact factor: 2.447

5.  Consecutive exotropia: why does it happen, and can medial rectus advancement correct it?

Authors:  Bhambi Gesite-de Leon; Joseph L Demer
Journal:  J AAPOS       Date:  2014-11-12       Impact factor: 1.220

6.  Long-term surgical outcomes of patients with consecutive exotropia.

Authors:  Haeng-Jin Lee; Young Suk Yu; Seong-Joon Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-13       Impact factor: 3.117

7.  Intraoperative Findings in Consecutive Exotropia with and without Adduction Deficit.

Authors:  Sarah R Hatt; David A Leske; Jae Ho Jung; Jonathan M Holmes
Journal:  Ophthalmology       Date:  2017-02-24       Impact factor: 12.079

8.  Human error in strabismus surgery: quantification with a sensitivity analysis.

Authors:  Sander Schutte; Jan Roelof Polling; Frans C T van der Helm; Huib J Simonsz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-25       Impact factor: 3.117

9.  Clinical risk factors for the development of consecutive exotropia: a comparative clinical study.

Authors:  Hande Taylan Sekeroglu; Kadriye Erkan Turan; Jale Karakaya; Emin Cumhur Sener; Ali Sefik Sanac
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

10.  Characteristics and surgical outcomes of consecutive exotropia of different etiologies.

Authors:  Mayu Sawada; Akiko Hikoya; Takashi Negishi; Yoshihiro Hotta; Miho Sato
Journal:  Jpn J Ophthalmol       Date:  2015-08-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.